Recent Finacing
Recent Raise
Exai Bio develops an RNA-based liquid biopsy platform that measures cell-free orphan non-coding oncRNA in blood and applies AI/ML analytics to generate tumor-specific predictive models and actionable clinical insights.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Exai Bio.
